Fintel reports that on February 12, 2025, Craig-Hallum initiated coverage of Myriad Genetics (NasdaqGS:MYGN) with a Buy ...
Tribeca Grill, a restaurant that played a large part in bringing New York’s once derelict Tribeca to life as of 1990, will ...
Shares of Myriad Genetics, Inc. (NASDAQ:MYGN – Get Free Report) have earned a consensus recommendation of “Hold” from the fourteen analysts that are covering the company, MarketBeat reports. Three ...
Myriad Uranium (OTCQB:MYRUF) has issued 612,164 common shares to FirstAmerican Energy Fuels to acquire the Red Basin Uranium project. The project is comprised of 86 lode claims in the Red Basin area ...
Myriad Uranium Corp. (CSE: M) (OTCQB: MYRUF) (FSE: C3Q) ("Myriad" or the "Company") is pleased to announce that it has ...
Myriad Genetics, Inc. (MYGN), a genetic and genomic tumor testing and precision medicine provider, and INTERLINK Care Management, ...
The Apple Health Study will use data from myriad Apple products to glean new insights in physical and mental health.
Myriad Genetics (MYGN) and Lumea have signed an agreement to integrate Myriad’s advanced molecular diagnostic tests – Prolaris Prostate Cancer ...
Myriad Genetics and Lumea Inc. partner to integrate molecular diagnostics into Lumea's digital pathology platform, enhancing cancer care efficiency. Myriad Genetics and Lumea Inc. have announced a ...
SALT LAKE CITY, Feb. 06, 2025 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic and genomic tumor ...
SALT LAKE CITY, Feb. 05, 2025 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic and genomic tumor testing and precision medicine, and Lumea Inc., a leader in digital ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results